PHARMA LINK
Board
1 director, last change in 2023Director (not named in the articles)
since 03-04-2023
term until 02-04-2029
earlier director, until 17-04-2023
listed in the 2025 annual accounts, filed on 23-06-2026
Mandates through the years
5 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
Director
Director
Managing director
BoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
-
- Director, appointed by deed of 09-05-2019, until 09-05-2019
- Director (not named in the articles), appointed by deed of 17-04-2023, still in office
- Director, until 17-04-2023
-
- Director, appointed by deed of 09-05-2019, until 09-05-2019
- Director, until 02-11-2020
- Director (not named in the articles), appointed by deed of 17-04-2023, until 08-08-2023
-
- Director, appointed by deed of 10-12-2020, until 17-04-2023
-
- Director, appointed by deed of 09-05-2019, until 17-04-2023
- Managing director, appointed by deed of 09-05-2019, last mentioned in 2019
-
- Managing director, until 09-05-2019
Control
Parent
Equity €1.5m
Profit €274,161 in 2025 (profit €250,338 in 2024)
Checked score
Source: accounts 2025
99.2%
This company
PHARMA LINK
Equity €149,586
Profit €128,563 in 2025
Capital
- Capital
- €62,000
- Shares
- 250
- Contribution per share
- €248
- Equity per share
- €598 in 2025
- Source
- deed of 17-04-2023
Owners through the years
as the annual accounts name themOwners as a list
-
- 2019 to 2025: 99.2%
-
- 2014 to 2016: 100%
- 2017 to 2018: 99%
Source: lists of holdings in the owners' accounts
Articles of association
deed of 17-04-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Bij gewone meerderheid kan algemene vergadering aan bepaalde bestuurders bezoldiging toekennen, algemene vergadering bij kennisgeving”“Raad kan voorzitter onder leden benoemen, fysiek in België of buitenland op plaats in oproeping,op afstand via teleconferentie of…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 18:00
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 17-11-2021 ↗
- all shares
Capital over time
- 17-04-2023 Capital stated in 2 deeds · €62,000 · 250 shares